Cristian Moldovan
Overview
Explore the profile of Cristian Moldovan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tigu A, Munteanu R, Moldovan C, Rares D, Kegyes D, Tomai R, et al.
Cell Death Discov
. 2024 Nov;
10(1):471.
PMID: 39551787
Receptor tyrosine kinases (RTKs) are key cell surface receptors involved in cell communication and signal transduction, with great importance in cell growth, differentiation, survival, and metabolism. Dysregulation of RTKs, such...
2.
Zimta A, Cenariu D, Tigu A, Moldovan C, Jurj A, Pop L, et al.
Med Pharm Rep
. 2024 May;
97(2):184-195.
PMID: 38746032
Background And Aims: The carcinogenic effect of arsenic is a subject of controversy in relation to breast cancer. In our current research, we aimed to simulate the effects of chronic...
3.
Zimta A, Cenariu D, Tigu A, Moldovan C, Jurj A, Pirlog R, et al.
Food Chem Toxicol
. 2024 Feb;
186:114523.
PMID: 38382870
The carcinogenic role of cadmium (Cd) in breast cancer is still debatable. Current data points to duration of exposure as the most important element. In our study, we designed an...
4.
David L, Onaciu A, Toma V, Borsa R, Moldovan C, Tigu A, et al.
Biosensors (Basel)
. 2024 Jan;
14(1).
PMID: 38248418
This study delves into the intricate interaction between DNA and nanosystems, exploring its potential implications for biomedical applications. The focus lies in understanding the adsorption geometry of DNA when in...
5.
Moldovan C, Onaciu A, Toma V, Munteanu R, Gulei D, Moldovan A, et al.
RSC Adv
. 2023 Nov;
13(45):31641-31658.
PMID: 37908656
Apoptosis, the most extensively studied type of cell death, is known to play a crucial role in numerous processes such as elimination of unwanted cells or cellular debris, growth, control...
6.
Onaciu A, Toma V, Moldovan C, Tigu A, Cenariu D, Culic C, et al.
Sensors (Basel)
. 2023 Jan;
23(1).
PMID: 36616944
DNA methylation is a crucial epigenetic hallmark of cancer development but the experimental methods able to prove nanoscale modifications are very scarce. Over time, Raman and its counterpart, surface-enhanced Raman...
7.
Bartos A, Iancu I, Ciobanu L, Onaciu A, Moldovan C, Moldovan A, et al.
Nanomaterials (Basel)
. 2022 Aug;
12(16).
PMID: 36014698
Sorafenib is a multikinase inhibitor that has received increasing attention due to its high efficacy in hepatocellular carcinoma treatment. However, its poor pharmacokinetic properties (limited water solubility, rapid elimination, and...
8.
Pruteanu L, Braicu C, Modos D, Jurj M, Raduly L, Zanoaga O, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563174
Triple negative breast cancer (TNBC) is currently associated with a lack of treatment options. Arsenic derivatives have shown antitumoral activity both in vitro and in vivo; however, their mode of...
9.
Barbalata C, Porfire A, Sesarman A, Rauca V, Banciu M, Muntean D, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683821
An increasing number of studies published so far have evidenced the benefits of Simvastatin (SIM) and Doxorubicin (DOX) co-treatment in colorectal cancer. In view of this, the current study aimed...
10.
Thureau S, Lebret L, Lequesne J, Cabourg M, Dandoy S, Gouley C, et al.
Cancers (Basel)
. 2021 Mar;
13(4).
PMID: 33670339
Sarcopenia is frequent in patients treated with radiation therapy (RT) or radiochemotherapy (RTCT) for head and neck squamous cell carcinomas. Sarcopenia is associated with poor disease-free survival and overall survival...